Wall Street analysts remain bullish on Eli Lilly, boasting an Average Brokerage Recommendation (ABR) of 1.46, largely between ...

Just two days after Novo Nordisk launched Wegovy (semaglutide 2.4 mg) in India, Eli Lilly received regulatory approval for the KwikPen® format of its rival therapy Mounjaro (tirzepatide) ...

Since the city's establishment in the 1820s, Indianapolis has been a magnet for immigrants seeking opportunity and refuge.

A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. Cash flow is valuable, but it’s not everything ...

A PIL has claimed that licences for these drugs were issued without adequate data or India-specific trials and studies, ...

Exclusive Global Rights: Neurizon is granted exclusive global rights to Elanco's data package and related intellectual ...

Highlights: Neurizon® Therapeutics and Elanco Animal Health enter into an exclusive global licensing agreement Provides worldwide rights for Neurizon to ...

BENGALURU: The Health and Family Welfare Department has written to the Drug Controller General of India (DCGI), seeking an ...

New rules are reshaping the telehealth market for GLP-1s like Ozempic and Wegovy, potentially impacting access to these drugs ...

The Howard County Board of Education is suing several Big Pharma companies for allegedly inflating insulin prices, affecting ...

The HHS wants to move oversight of the controversial drug discount program to the CMS, which has a more aggressive history ...

Linear relationship seen for waist circumference, BP; reduction in HOMA-IR, hemoglobin A1c seen with modest weight reduction.